Ashita Gurnani
Research Assistant Professor, Neurology
![Ashita Gurnani](/camed/files/2021/02/Ashita-Gurnani-144x150.jpg)
Websites
Education
- Univ Colo Colo Sprgs, PhD
- Univ Colo Colo Sprgs, MA
Publications
- Published on 7/3/2024
Kang M, Li C, Mahajan A, Spat-Lemus J, Durape S, Chen J, Gurnani AS, Devine S, Auerbach SH, Ang TFA, Sherva R, Qiu WQ, Lunetta KL, Au R, Farrer LA, Mez J. Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment. JAMA Psychiatry. 2024 Jul 03. PMID: 38959008.
Read at: PubMed - Published on 4/12/2024
Wang Y, Huang J, Ang TFA, Zhu Y, Tao Q, Mez J, Alosco M, Denis GV, Belkina A, Gurnani A, Ross M, Gong B, Han J, Lunetta KL, Stein TD, Au R, Farrer LA, Zhang X, Qiu WQ. The association between circulating CD34+CD133+ endothelial progenitor cells and reduced risk of Alzheimer's disease in the Framingham Heart Study. Explor Med. 2024; 5(2):193-214. PMID: 38854406.
Read at: PubMed - Published on 10/26/2023
Ferretti MT, Ding H, Au R, Liu C, Devine S, Auerbach S, Mez J, Gurnani A, Liu Y, Santuccione A, Ang TFA. Maximizing utility of neuropsychological measures in sex-specific predictive models of incident Alzheimer's disease in the Framingham Heart Study. Alzheimers Dement. 2024 Feb; 20(2):1112-1122. PMID: 37882354.
Read at: PubMed - Published on 1/19/2023
Hwang PH, Ang TFA, De Anda-Duran I, Liu X, Liu Y, Gurnani A, Mez J, Auerbach S, Joshi P, Yuan J, Devine S, Au R, Liu C. Examination of potentially modifiable dementia risk factors across the adult life course: The Framingham Heart Study. Alzheimers Dement. 2023 Jul; 19(7):2975-2983. PMID: 36656649.
Read at: PubMed - Published on 1/18/2023
Wang Y, Huang J, Ang TFA, Zhu Y, Tao Q, Mez J, Alosco M, Denis GV, Belkina A, Gurnani A, Ross M, Gong B, Han J, Lunetta KL, Stein TD, Au R, Farrer LA, Zhang X, Qiu WQ. Circulating Endothelial Progenitor Cells Reduce the Risk of Alzheimer's Disease. medRxiv. 2023 Jan 18. PMID: 36711847.
Read at: PubMed - Published on 2/20/2020
Gurnani AS, Lin SS, Gavett BE. The Colorado Cognitive Assessment (CoCA): Development of an Advanced Neuropsychological Screening Tool. Arch Clin Neuropsychol. 2020 Feb 20; 35(2):176-187. PMID: 31711105.
Read at: PubMed - Published on 11/22/2016
Gurnani AS, Gavett BE. The Differential Effects of Alzheimer's Disease and Lewy Body Pathology on Cognitive Performance: a Meta-analysis. Neuropsychol Rev. 2017 03; 27(1):1-17. PMID: 27878426.
Read at: PubMed - Published on 11/1/2016
John SE, Gurnani AS, Bussell C, Saurman JL, Griffin JW, Gavett BE. The effectiveness and unique contribution of neuropsychological tests and the d latent phenotype in the differential diagnosis of dementia in the uniform data set. Neuropsychology. 2016 11; 30(8):946-960. PMID: 27797542.
Read at: PubMed - Published on 10/6/2016
Gavett BE, Gurnani AS, Saurman JL, Chapman KR, Steinberg EG, Martin B, Chaisson CE, Mez J, Tripodis Y, Stern RA. Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults. PLoS One. 2016; 11(10):e0164492. PMID: 27711147.
Read at: PubMed - Published on 1/1/2016
Gavett BE, John SE, Gurnani AS, Bussell CA, Saurman JL. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease. J Alzheimers Dis. 2016; 49(2):531-45. PMID: 26444761.
Read at: PubMed
View 4 more publications: View full profile at BUMC